Medeon Biodesign (Taiwan) Market Value
| 6499 Stock | TWD 43.20 1.20 2.70% |
| Symbol | Medeon |
Medeon Biodesign 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medeon Biodesign's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medeon Biodesign.
| 09/25/2024 |
| 11/24/2024 |
If you would invest 0.00 in Medeon Biodesign on September 25, 2024 and sell it all today you would earn a total of 0.00 from holding Medeon Biodesign or generate 0.0% return on investment in Medeon Biodesign over 60 days. Medeon Biodesign is related to or competes with StShine Optical, Bioteque, SciVision Biotech. More
Medeon Biodesign Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medeon Biodesign's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medeon Biodesign upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 12.48 | |||
| Value At Risk | (1.93) | |||
| Potential Upside | 2.55 |
Medeon Biodesign Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medeon Biodesign's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medeon Biodesign's standard deviation. In reality, there are many statistical measures that can use Medeon Biodesign historical prices to predict the future Medeon Biodesign's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.32) | |||
| Treynor Ratio | (1.23) |
Medeon Biodesign Backtested Returns
Medeon Biodesign has Sharpe Ratio of -0.0036, which conveys that the firm had a -0.0036% return per unit of risk over the last 3 months. Medeon Biodesign exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medeon Biodesign's Mean Deviation of 1.05, insignificant risk adjusted performance, and Standard Deviation of 1.84 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.026, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Medeon Biodesign's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medeon Biodesign is expected to be smaller as well. At this point, Medeon Biodesign has a negative expected return of -0.0067%. Please make sure to verify Medeon Biodesign's market risk adjusted performance, coefficient of variation, jensen alpha, as well as the relationship between the mean deviation and standard deviation , to decide if Medeon Biodesign performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.42 |
Modest reverse predictability
Medeon Biodesign has modest reverse predictability. Overlapping area represents the amount of predictability between Medeon Biodesign time series from 25th of September 2024 to 25th of October 2024 and 25th of October 2024 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medeon Biodesign price movement. The serial correlation of -0.42 indicates that just about 42.0% of current Medeon Biodesign price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.42 | |
| Spearman Rank Test | -0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 2.03 |
Medeon Biodesign lagged returns against current returns
Autocorrelation, which is Medeon Biodesign stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Medeon Biodesign's stock expected returns. We can calculate the autocorrelation of Medeon Biodesign returns to help us make a trade decision. For example, suppose you find that Medeon Biodesign has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Medeon Biodesign regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Medeon Biodesign stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Medeon Biodesign stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Medeon Biodesign stock over time.
Current vs Lagged Prices |
| Timeline |
Medeon Biodesign Lagged Returns
When evaluating Medeon Biodesign's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Medeon Biodesign stock have on its future price. Medeon Biodesign autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Medeon Biodesign autocorrelation shows the relationship between Medeon Biodesign stock current value and its past values and can show if there is a momentum factor associated with investing in Medeon Biodesign.
Regressed Prices |
| Timeline |
Pair Trading with Medeon Biodesign
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medeon Biodesign position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medeon Biodesign will appreciate offsetting losses from the drop in the long position's value.Moving against Medeon Stock
The ability to find closely correlated positions to Medeon Biodesign could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medeon Biodesign when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medeon Biodesign - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medeon Biodesign to buy it.
The correlation of Medeon Biodesign is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medeon Biodesign moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medeon Biodesign moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medeon Biodesign can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Medeon Stock Analysis
When running Medeon Biodesign's price analysis, check to measure Medeon Biodesign's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medeon Biodesign is operating at the current time. Most of Medeon Biodesign's value examination focuses on studying past and present price action to predict the probability of Medeon Biodesign's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medeon Biodesign's price. Additionally, you may evaluate how the addition of Medeon Biodesign to your portfolios can decrease your overall portfolio volatility.